Medications are best complemented with digital health applications. The benefits would be seen not just in patients and healthcare providers, but would extend to all other sectors like pharma, devices and insurance companies! So, add that digital zing to chronic disease management!

Digital PSPs can play integrators, generate evidence in real world settings, and accelerate the journey to better patient health. As when the patient wins, everyone wins. 

Robust Patient Support Programmes help Pharmaceutical Companies to deal with the intricacies of chronic disease management; an important aspect of which is addressing side-effects to in turn improve medication adherence.

With technological interventions in today’s time, ease and efficiency have
been two of the most important aspects of our everyday life. Considering the drawbacks of
traditional Patient Support Programs (PSPs), pharmaceutical companies and healthcare
providers are working towards offering a holistic and effective approach using the internet and
digital mediums. Research and surveys have shown positive outcomes as patients respond well
when approached regularly during their care and this has shown that digital programs have the
potential benefits.

The reasons for poor adherence are multifactorial (patient, physician, disease and health-system related); hence the measures to improve adherence need to be multi-pronged as well! Bringing the patient into focus and enabling them to take informed daily decisions that affect adherence- this sums up effective continuous and holistic patient engagement. A great way to do this digitally: with the Wellthy app!